ZA200809012B - Intravenous antiviral treatments - Google Patents

Intravenous antiviral treatments

Info

Publication number
ZA200809012B
ZA200809012B ZA200809012A ZA200809012A ZA200809012B ZA 200809012 B ZA200809012 B ZA 200809012B ZA 200809012 A ZA200809012 A ZA 200809012A ZA 200809012 A ZA200809012 A ZA 200809012A ZA 200809012 B ZA200809012 B ZA 200809012B
Authority
ZA
South Africa
Prior art keywords
antiviral treatments
intravenous
intravenous antiviral
treatments
antiviral
Prior art date
Application number
ZA200809012A
Other languages
English (en)
Inventor
Yarlagadda Sudhakara Babu
Pooran Chand
Shanta Bantia
Shane Arnold
John Michael Kilpatrick
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of ZA200809012B publication Critical patent/ZA200809012B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200809012A 2006-02-13 2008-10-21 Intravenous antiviral treatments ZA200809012B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77274806P 2006-02-13 2006-02-13

Publications (1)

Publication Number Publication Date
ZA200809012B true ZA200809012B (en) 2010-03-31

Family

ID=40631372

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200809012A ZA200809012B (en) 2006-02-13 2008-10-21 Intravenous antiviral treatments

Country Status (3)

Country Link
US (6) US20070203241A1 (zh)
CN (1) CN101420948A (zh)
ZA (1) ZA200809012B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101420948A (zh) 2006-02-13 2009-04-29 拜奥克里斯特制药公司 静脉内抗病毒治疗
US11166999B1 (en) 2020-08-18 2021-11-09 Morehouse School Of Medicine Method of treating coronavirus infections
US11266723B1 (en) 2020-08-18 2022-03-08 Morehouse School Of Medicine Methods and compositions for treating coronavirus infections

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5453533A (en) * 1994-04-14 1995-09-26 The University Of Alabama At Birmingham Inhibitors of influenza virus neuraminidase and methods of making and using the same
PL330407A1 (en) * 1996-06-14 1999-05-10 Biocryst Pharmaceuticals Substituted cyclopentane compounds useful as neuraminidaze inhibitors
SK8712000A3 (en) 1997-12-17 2000-11-07 Biocryst Pharm Inc Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
AU1520300A (en) * 1998-11-05 2000-05-29 Biocryst Pharmaceuticals, Inc. New cyclopentane and cyclopentene compounds and use for detecting influenza virus
US6762316B1 (en) * 1999-06-28 2004-07-13 Biocryst Pharmaceuticals, Inc. Preparation of substituted cyclopentane and cyclopentene compounds and certain intermediates
HUP0202097A2 (en) * 1999-06-28 2002-10-28 Biocryst Pharm Inc Process for preparing substituted cyclopentane derivatives and novel crystalline form of these derivatives
GB0015324D0 (en) 2000-06-22 2000-08-16 Biota Scient Management Medicaments
US6605302B2 (en) 2001-07-17 2003-08-12 Osmotica Corp. Drug delivery device containing oseltamivir and an H1 antagonist
CN101420948A (zh) 2006-02-13 2009-04-29 拜奥克里斯特制药公司 静脉内抗病毒治疗

Also Published As

Publication number Publication date
US20180015063A1 (en) 2018-01-18
US20220040137A1 (en) 2022-02-10
US10391075B2 (en) 2019-08-27
US20070203241A1 (en) 2007-08-30
US20190358187A1 (en) 2019-11-28
US11464755B2 (en) 2022-10-11
US20120059057A1 (en) 2012-03-08
US9770427B2 (en) 2017-09-26
CN101420948A (zh) 2009-04-29
US20140309301A1 (en) 2014-10-16
US8778997B2 (en) 2014-07-15

Similar Documents

Publication Publication Date Title
IL241919A (en) Catheter system
IL196559A0 (en) Combination therapy
GB0712494D0 (en) Substrate reduction therapy
ZA200809559B (en) Photoplethysmography
EP2081483A4 (en) ANTIEXTRAVASATIONSKATHETER
GB0709791D0 (en) Antiviral agents
ZA200806756B (en) Hetero-bycyclic antiviral compounds
GB0624874D0 (en) Treatment
AP2011005695A0 (en) Therapeutic antiviral poptides.
HU3768U (en) Intravenous catheter
IL196556A0 (en) Combination therapy
GB0600692D0 (en) Well treatment
GB0707000D0 (en) Antiviral agents
EP2054061A4 (en) COMBINATION THERAPY
GB0603926D0 (en) Syringes
EP1976590A4 (en) CATHETER
GB0613952D0 (en) Antiviral agent
GB0805264D0 (en) Antiviral agents
GB0625783D0 (en) Medicament
GB0614034D0 (en) Antiviral compounds
ZA200902203B (en) Combination therapy
GB0813307D0 (en) Retro-reflector
ZA200809012B (en) Intravenous antiviral treatments
KR101992585B9 (ko) 정맥내 항바이러스 치료
GB0615064D0 (en) Medicament